Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
about
Th17 cells in autoimmune and infectious diseasesImmunologic biomarkers for clinical and therapeutic management of psoriasis.Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosisSerum levels of TNF-α, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity.Characterization of Th17 and FoxP3(+) Treg Cells in Paediatric Psoriasis Patients.IL-17A, IL-22, IL-6, and IL-21 Serum Levels in Plaque-Type Psoriasis in Brazilian Patients.Therapeutic Effects of Erythroid Differentiation Regulator 1 on Imiquimod-Induced Psoriasis-Like Skin Inflammation.Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in miceControl of autoimmune inflammation by celastrol, a natural triterpenoid.Association between plasma interleukin-17 levels and risk of psoriasis: a meta-analysis.Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis.Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis.Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis VulgarisMyeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor MechanismsInfluence of psoriasis on circulatory system function assessed in echocardiography.CD4 T-Cell Dysregulation in Psoriatic Arthritis Reveals a Regulatory Role for IL-22.Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease.Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.Regulation of T helper cell responses during antigen presentation by norepinephrine-exposed endothelial cells.Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.Elevation of serum squamous cell carcinoma antigen 2 in patients with psoriasis: associations with disease severity and response to the treatment.Effect of narrow band ultraviolet B phototherapy on T helper 17 cell specific cytokines (interleukins-17, 22 and 23) in psoriasis vulgaris.The potential role of Th17 lymphocytes in patients with psoriasis.Staphylococcus aureus enterotoxins modulate IL-22-secreting cells in adults with atopic dermatitis.Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumabThe level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis
P2860
Q21284677-916C302B-59C8-4212-82AC-BAC38E01A4A4Q34030644-3D334F3C-CAE1-4A85-8416-FA12A5567B3BQ34218639-CF74C599-E88A-4AC7-85EE-42AA2DACEF99Q35005069-E61144FF-AD2E-4B44-8EF1-F469BD3BC356Q35155926-9BC31D38-2411-4CFB-A677-1F93D39FB9E6Q35871966-F9E090A3-8395-4F3D-B090-4AAED289CF36Q35999113-0ABBAA9D-9CF3-42C7-BF97-3BCED866515AQ36667189-A094F593-BD2A-4F51-AABD-0FB3A245C649Q37032431-3D7E2279-1E86-41B2-AC8D-52D349B93097Q38894091-3E47238C-9D41-4D09-89BB-3957C3575949Q39031468-1F9E3483-086E-480F-B8A9-D57C60E74607Q40868178-6CE60F1F-FB30-4B9F-92A8-EE26176580AAQ41271580-E72787AB-7674-4FFD-ADED-10A5F1A4B0B9Q41460287-56A4A452-4D4E-4816-B6C7-7CC7C5091041Q41485262-552D59B2-56F8-4503-8267-16274EE01CA1Q41631142-9EF85952-A06C-4198-A7AF-234F05CD656AQ45795234-933DD9EB-A5B9-413D-A905-AFE20AC7D8AEQ47161839-5C020001-9CB9-4960-80D9-FEAC042BCCA5Q47851802-9F280526-DD3D-4C42-BC35-EDDEE9BA85C2Q47955575-F32DB624-0EAD-419B-8439-2FFF760BE3E4Q49249983-828FE174-EAEA-4859-9DC7-D2313B366E61Q52886990-7F0EFFA3-3D3A-487E-B3AB-9651A981E4F6Q53803495-5B024ECB-A120-4A4A-AC2C-9BF568791EBEQ55077651-8AF5B75A-BF95-4F9A-86C0-22F6959A881EQ55335008-45A5F28F-F476-4765-A3C2-CE648AD35827Q58720009-D961A08A-FAA0-40F2-A792-11E4E5F55664Q58727105-E0FFA11F-DFF4-4679-B8D4-01C737FE1704
P2860
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
@en
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
@nl
type
label
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
@en
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
@nl
prefLabel
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
@en
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.
@nl
P2860
P50
P356
P1433
P1476
Serum levels of selected Th17 and Th22 cytokines in psoriatic patients
@en
P2093
Maria Juszkiewicz-Borowiec
Małgorzata Kowal
P2860
P304
P356
10.1155/2013/856056
P577
2013-10-31T00:00:00Z